GlobeNewswire Inc | Nov 1, 2021 08:30AM EDT

November 01, 2021

CAMBRIDGE, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd.(Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at8:30 a.m. ETonWednesday, November 10, 2021, to discuss its third quarter 2021 financial results and provide a business update.

The webcast of the conference call may be accessed by visiting the Events section in the Investor Relations page of theWave Life Scienceswebsite atwww.wavelifesciences.com. The live teleconference may be accessed by dialing (866) 220-8068 (domestic) or (470) 495-9153 (international) and entering conference ID: 6995569. Following the conference call, an archived version of the call will be available on the website.

AboutWave Life SciencesWave Life Sciences(Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the companys proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visitwww.wavelifesciences.comand follow Wave on Twitter @WaveLifeSci.

Investor Contact:Kate Rausch617-949-4827krausch@wavelifesci.com

Media Contact:Alicia Suter617-949-4817asuter@wavelifesci.com